24.30
price down icon1.46%   -0.36
after-market Handel nachbörslich: 24.34 0.04 +0.16%
loading

Pfizer Inc Aktie (PFE) Neueste Nachrichten

pulisher
Nov 04, 2025

Pfizer Receives Early Termination of FTC Review for Metsera Acquisition - geneonline.com

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Q3 Revenue Falls 7% To US$16.7 Billion - BusinessToday Malaysia

Nov 04, 2025
pulisher
Nov 04, 2025

Defining The 'Superior' Bid In Pfizer-Novo Legal Battle - Law360

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera - Denver Gazette

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer’s Earnings Call: Strategic Gains Amid Challenges - TipRanks

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer (NYSE:PFE) Trading Down 1.4%Time to Sell? - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

PFIZER INC : JP Morgan is Neutral - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

Metsera in the middle of Novo, Pfizer bidding war - BioWorld MedTech

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup MetseraWSJ - The Wall Street Journal

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer and Novo fatten their bids for weight-loss drugmaker Metsera - Axios

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Weight-Loss $9B Suit: Delaware Court Holds Off Amid High-Stakes Fight Over Metsera - USA Herald

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer ‘Unwavering’ In Pursuit Of Metsera - Citeline News & Insights

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Earnings: In-Line Quarter Despite Covid Product Weakness as Metsera Drama Intensifies - Morningstar

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Inc (PFE) Q3 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... By GuruFocus - Investing.com Canada

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Inc (PFE) Q3 2025 Earnings Call Highlights: Navigating Revenue Declines and Strategic ... - Yahoo Finance

Nov 04, 2025
pulisher
Nov 04, 2025

Weight-loss wars: $10bn hostile battle pits Pfizer against Novo Nordisk - Financial Times

Nov 04, 2025
pulisher
Nov 04, 2025

Novo Nordisk Boosts Metsera Bid To $10B After Pfizer Suit - Law360

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Can't Freeze $9B Weight-Loss Drug Fight For Now - Law360

Nov 04, 2025
pulisher
Nov 04, 2025

How Pfizer's (PFE) Metsera Legal Fight and Q3 Dip Could Reshape Its Innovation Strategy - Yahoo Finance

Nov 04, 2025
pulisher
Nov 04, 2025

Novo, Pfizer Are Battling To Buy The Future Of Weight-Loss — But Viking Already Owns It - Benzinga

Nov 04, 2025
pulisher
Nov 04, 2025

Traders Purchase Large Volume of Pfizer Call Options (NYSE:PFE) - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer, Novo Nordisk Intensify Fight For Metsera As Buyout Offers Continue To Climb - Benzinga

Nov 04, 2025
pulisher
Nov 04, 2025

Novo Nordisk ups Metsera offer to $10B, outbidding Pfizer - The Business Journals

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Is Losing Its Fight With Novo Nordisk to Get Back in the Obesity-drug Game - 富途牛牛

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Narrows Its Outlook And Keeps The Optimism Flowing - Finimize

Nov 04, 2025
pulisher
Nov 04, 2025

Novo Nordisk Outbids Pfizer In $10 Billion Metsera Takeover Battle - Finimize

Nov 04, 2025
pulisher
Nov 04, 2025

Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera - Barron's

Nov 04, 2025
pulisher
Nov 04, 2025

Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Q3 Revenue Trends Are Uneven, Cost Cuts Drive EarningsPfizer (NYSE:PFE) - Benzinga

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Profit Falls Amid Lower Covid-19 Drug Demand - The Wall Street Journal

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Stock Falls on Third-Quarter Earnings. What Covid-19 Has to Do With It. - Barron's

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer, Novo Boost Bids for Obesity Drugmaker Metsera in Takeover Saga - Bloomberg

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Q3 2025 slides: EPS beats expectations as company raises guidance - Investing.com

Nov 04, 2025
pulisher
Nov 04, 2025

Novo Nordisk tops Pfizer in bidding war for obesity startup Metsera - Proactive financial news

Nov 04, 2025
pulisher
Nov 04, 2025

Metsera’s Shares Spike Amid Acquisition Proposals from Novo Nordisk and Pfizer - StocksToTrade

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer (PFE) Q3 2025 Earnings Call Transcript - The Globe and Mail

Nov 04, 2025
pulisher
Nov 04, 2025

Transcript : Pfizer Inc., Q3 2025 Earnings Call, Nov 04, 2025 - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

Delaware court won't rule on Pfizer/Novo battle for Metsera today - Seeking Alpha

Nov 04, 2025
pulisher
Nov 04, 2025

Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo - Reuters

Nov 04, 2025
pulisher
Nov 04, 2025

Metsera again chooses Novo as bidding war with Pfizer intensifies - BioPharma Dive

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer : Quarterly Corporate PerformanceThird Quarter 2025 Prepared Remarks - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up - Yahoo Finance

Nov 04, 2025
pulisher
Nov 04, 2025

Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer - Houston Chronicle

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer reports strong Q3 earnings, raises full-year profit guidance - Proactive financial news

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Q3 Earnings Beat Estimates, Sales Decline as COVID Demand Cools - TradingView

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer’s Q3 Earnings Beat on Top and Bottom Lines - AOL.com

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Inc. Reaffirms Earnings Guidance for the Full Year of 2025 - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup - The Wall Street Journal

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer & Novo boost Metsera bids, Hertz stock skyrockets - Yahoo Finance

Nov 04, 2025
pulisher
Nov 04, 2025

Novo Nordisk Hikes Metsera Bid to up to $10B in Competition With Rival Pfizer - U.S. News & World Report

Nov 04, 2025
pulisher
Nov 04, 2025

Global markets live: Tesla, Amazon, Palantir, Pfizer, Merck… - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Inc. 2025 Q3ResultsEarnings Call Presentation (NYSE:PFE) 2025-11-04 - Seeking Alpha

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer says drug pricing agreement with US government has no impact on 2025 guidance - MarketScreener

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer’s revenue falls as COVID sales and vaccine recommendations continue to fade - MSN

Nov 04, 2025
pulisher
Nov 04, 2025

Here's What Key Metrics Tell Us About Pfizer (PFE) Q3 Earnings - Yahoo! Finance Singapore

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer Boosts Profit View While Chasing Obesity Startup Metsera - Bloomberg

Nov 04, 2025
pulisher
Nov 04, 2025

Dow Dips Over 400 Points; Pfizer Earnings Top Estimates - Benzinga

Nov 04, 2025
pulisher
Nov 04, 2025

Pfizer COVID-19 vaccine sales tumble after government guidance on the shots narrows - Yahoo Finance

Nov 04, 2025
$123.00
price up icon 0.78%
drug_manufacturers_general SNY
$49.11
price down icon 1.88%
$296.70
price up icon 0.13%
drug_manufacturers_general NVO
$48.25
price down icon 1.75%
drug_manufacturers_general MRK
$83.86
price up icon 1.66%
Kapitalisierung:     |  Volumen (24h):